Epclusa — Medica
Patient has been started on sofosbuvir/velpatasvir for an approved indication
Initial criteria
- Prescription is for completion of an approved treatment course per approved indication
Approval duration
to complete course therapy (e.g., remaining weeks up to 12 or 24 weeks as applicable)